MedPath

Eptifibatide

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION. EPTIFIBATIDE injection, for intravenous useInitial U.S. Approval: 1998

Approved
Approval ID

88a37f9c-496b-4a6b-9665-4550abba04f1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 28, 2021

Manufacturers
FDA

Mylan Institutional LLC

DUNS: 790384502

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

eptifibatide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67457-631
Application NumberANDA203258
Product Classification
M
Marketing Category
C73584
G
Generic Name
eptifibatide
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 17, 2018
FDA Product Classification

INGREDIENTS (3)

EPTIFIBATIDEActive
Quantity: 0.75 mg in 1 mL
Code: NA8320J834
Classification: ACTIB
CITRIC ACID MONOHYDRATEInactive
Quantity: 5.25 mg in 1 mL
Code: 2968PHW8QP
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

eptifibatide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67457-629
Application NumberANDA203258
Product Classification
M
Marketing Category
C73584
G
Generic Name
eptifibatide
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 17, 2018
FDA Product Classification

INGREDIENTS (3)

EPTIFIBATIDEActive
Quantity: 2 mg in 1 mL
Code: NA8320J834
Classification: ACTIB
CITRIC ACID MONOHYDRATEInactive
Quantity: 5.25 mg in 1 mL
Code: 2968PHW8QP
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

eptifibatide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67457-630
Application NumberANDA203258
Product Classification
M
Marketing Category
C73584
G
Generic Name
eptifibatide
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 17, 2018
FDA Product Classification

INGREDIENTS (3)

CITRIC ACID MONOHYDRATEInactive
Quantity: 5.25 mg in 1 mL
Code: 2968PHW8QP
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
EPTIFIBATIDEActive
Quantity: 2 mg in 1 mL
Code: NA8320J834
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Eptifibatide - FDA Drug Approval Details